RESEARCH

 

Stillbirth in rural Bangladesh: arsenic exposure and other etiological factors: a report from Gonoshasthaya Kendra

 

Mortinaissances dans le Bangladesh rural : exposition à l'arsenic et autres facteurs étiologiques

 

Mortinatalidad en el Bangladesh rural: exposición a arsénico y otros factores etiológicos

 

 

Nicola CherryI,1; Kashem ShaikhII; Corbett McDonaldIII; Zafrullah ChowdhuryII

ICommunity and Occupational Medicine Program, University of Alberta, Edmonton, AB, Canada
IIGonoshasthaya Kendra, Dhaka, Bangladesh
IIIDepartment of Occupational and Environmental Medicine, National Heart and Lung Institute, Imperial College London, London, England

 

 


ABSTRACT

OBJECTIVE: To use data collected by Gonoshasthaya Kendra, a large nongovernmental organization providing health care to some 600 villages, to describe the epidemiological pattern of stillbirth and any additional contribution made by arsenic contamination of hand-pump wells in Bangladesh.
METHODS: Completed pregnancies and outcomes (n = 30 984) for two calendar years, together with existing data on 26 socioeconomic and health factors were selected for study. The health care in these villages was administered from 16 geographical centres; information on the average arsenic concentration in each centre was obtained from the National Hydrochemical Survey. After univariate analysis, a multivariate, multilevel, logistic model for stillbirth was developed. The additional effect of arsenic was calculated having adjusted for all potential confounders thus identified.
FINDINGS: The overall stillbirth rate was 3.4% (1056/30 984) and increased with estimated arsenic concentration (2.96% at < 10 µg/l; 3.79% at 10 µg/l to < 50 µg/l; 4.43% at > 50 µg/l). Having adjusted for 17 socioeconomic and health factors, the odds ratios estimated for arsenic (with < 10 µg/l as reference) remained raised: 1.23 (95% confidence interval, CI: 0.87–1.74) at 10 µg/l to < 50 µg/l and 1.80 (95% CI: 1.14–2.86) at 50 µg/l or greater.
CONCLUSION: A increased risk of stillbirth is associated with arsenic contamination. This risk, substantial enough to be detected by an ecological approach and not readily attributable to unmeasured confounding, is essentially preventable and all efforts must be made to protect women at high risk.


RÉSUMÉ

OBJECTIF: Utiliser les données collectées par Gonoshasthaya Kendra, une importante organisation non gouvernementale délivrant des soins de santé à quelque 600 villages, pour décrire le schéma épidémiologique des mortinaissances et l'éventuelle contribution supplémentaire due à la contamination par l'arsenic des puits à pompe manuelle au Bangladesh.
MÉTHODES: On a sélectionné pour l'étude, sur deux années calendaires, un certain nombre de grossesses menées à terme et leur issue (n = 30 984) et relevé les données disponibles pour 26 facteurs socioéconomiques et sanitaires. Les soins de santé dans ces villages étaient administrés à partir de 16 centres géographiques, les valeurs des concentrations d'arsenic dans chacune de ces zones administratives étant fournies par l'Enquête hydrochimique nationale. Après application d'une analyse univariée, on a mis au point un modèle de régression logistique multivariée et multiniveaux de la mortinaissance. On a déterminé l'effet additionnel de l'arsenic en pratiquant des ajustements pour l'ensemble des facteurs de confusion potentiels.
RÉSULTATS: Le taux global de mortinaissance était de 3,4 % (1056/30 984) et augmentait avec la concentration d'arsenic estimée (soit 2,96 % pour moins de 10 µg/l d'arsenic ; 3,79 % entre 10 µg/l et 50 µg/l et 4,43 % pour 50 µg/l et plus). Une fois ajusté pour 17 facteurs socioéconomiques et sanitaires, l'odds ratio estimé pour l'arsenic (en prenant comme référence une concentration < 10 µg/l) restait élevé : 1,23 [intervalle de confiance à 95 % (IC) : 0,87 – 1,74] entre 10 µg/l et 50 µg/l et 1,80 (IC à 95 % : 1,14-2,86) pour 50 µg/l et plus.
CONCLUSION: La contamination par l'arsenic est associée à un risque accru de mortinaissance. Ce risque, dont l'ampleur est suffisante pour être détectée par une approche écologique et qu'on ne peut attribuer facilement à un facteur de confusion non mesuré, peut pour l'essentiel être prévenu et tous les efforts doivent être consentis pour protéger les femmes à haut risque.


RESUMEN

OBJETIVO: Utilizar los datos reunidos por Gonoshasthaya Kendra, una gran organización no gubernamental que dispensa atención de salud en unas 600 aldeas, para determinar el perfil epidemiológico de la mortinatalidad y el posible efecto adicional sobre esa variable de la contaminación por arsénico de los pozos con bomba manual en Bangladesh.
MÉTODOS: Se seleccionaron para el estudio los embarazos llevados a término y los resultados (n = 30 984) correspondientes a dos años civiles, junto con los datos existentes sobre 26 factores socioeconómicos y sanitarios. La atención de salud en esas aldeas se administraba desde 16 centros geográficos; a partir del Nacional Hydrochemical Survey se obtuvo la información sobre la concentración media de arsénico correspondiente a cada centro. Tras realizar un análisis unifactorial, se elaboró un modelo logístico multifactorial de varios niveles para la mortinatalidad. El efecto adicional del arsénico se calculó teniendo en cuenta todos los factores de confusión potenciales así identificados.
RESULTADOS: La tasa de mortinatalidad global era del 3,4% (1056/30 984) y aumentaba con la concentración de arsénico estimada (2,96% a < 10 µg/l; 3,79% a cifras de entre 10 µg/l y 50 µg/l; y 4,43% a valores > 50 µg/l). Ajustando los valores en función de 17 factores socioeconómicos y sanitarios, las razones de posibilidades estimadas para el arsénico (con < 10 µg/l como referencia) seguían siendo altas: 1,23 (intervalo de confianza del 95%, IC95%: 0,87-1,74) a entre 10 µg/l y 50µg/l, y 1,80 (IC95%: 1,14 - 2,86) a valores > 50 µg/l.
CONCLUSIÒN: La contaminación por arsénico lleva asociado un mayor riesgo de mortinatalidad. Este riesgo, suficientemente importante para ser detectado mediante estudios ecológicos y difícilmente atribuible a factores de confusión no determinados, es en último término prevenible. Debe hacerse todo lo posible para proteger a las mujeres en situación de alto riesgo.



 

 

Background

Stillbirth is a major cause of pregnancy loss, particularly in poor countries. In sub-Saharan Africa and southern Asia, some 5% of pregnancies end in this way, whereas in Europe and North America the proportion is generally less than 1%. In the latter regions, much is known about such causal factors as hypertension, obesity, eclampsia, advancing age and smoking.1 In poor countries, there has been much less research, and the main concern has been for early pregnancy, inadequate nutrition, endemic malaria, stature and poor physique, all or any of which may have an important role.2 Our immediate need is to determine whether, in Bangladesh, the widespread arsenic contamination of water in hand-pump tubewells is potentially hazardous for pregnant women. Though this question could be approached ecologically with the considerable information on the geographical distribution of arsenic in wells based on the National Hydrochemical Survey, together with stillbirth rates by district, the possibility of confounding by socioeconomic factors and health status also has to be excluded.

Serious natural contamination of water with arsenic and other minerals in village hand-pump tubewells in Bangladesh and West Bengal is well documented,3 as are the skin lesions that result.4–10 A wide range of other types of disease, mainly from occupational exposure to inhaled arsenic, have included internal cancers of the lung and other organs and various chronic inflammatory diseases, but effects on the outcome of pregnancy have not been clearly identified.11 However, the longstanding use of arsenic as an abortifacient, together with results from animal studies,12 suggests that such effects are not improbable, and there is evidence that arsenic concentrations in the urine of pregnant women reflect their level of chronic exposure.13 In 2001, a study in Bangladesh of pregnancy outcomes in 192 women, half in a village with high arsenic levels, found 17 stillbirths compared with seven in a similar village with low levels.14 A more recent study of 533 women drawn randomly from 74 villages, mostly with high arsenic concentrations (mean 277 µg/l; median 116 µg/l) showed evidence of increased risk of fetal and infant death.15 This study, although based on only 48 stillbirths, allowed analysis of reproductive history and educational status by logistic regression.15 A study of 202 pregnant women identified from a cross-sectional survey of almost 8000 people in 21 West Bengal villages found evidence of a significant increase in stillbirth at concentrations of > 200 µg/l.16 However, a study of 2006 pregnant women in three selected upazillas (subdistricts) found no association with stillbirth.17

There is still a requirement for evidence based on reliable data in well-supervised large populations exposed to arsenic over a range of concentrations. These requirements are largely met by Gonoshasthaya Kendra (GK; the People's Health Centre), a large, well established nongovernmental organization, which currently provides comprehensive health care for the entire population of about one million in some 600 villages, spread across four of Bangladesh's six main divisions. Most of the villages in the GK network are located in districts where the average arsenic concentration in hand-pump tubewells is low (< 50 µg/l), but many are in areas with average concentrations well above that; in addition, there is enormous variation between and within villages. Cross-sectional and case-referent surveys of skin lesions in a large sample of GK villages have shown an average prevalence of 0.37% at concentrations < 5 µg/l, rising to 6.84% at > 50 µg/l.18,19

As GK has always maintained a complete census of residents in its villages and has systematically recorded all pregnancies with outcome, together with some 30 health and socioeconomic variables, these data should provide useful information on the epidemiology of stillbirth in this population of over a million residents in rural Bangladesh against which any additional effect of arsenic can be assessed.

 

Methods

Completed pregnancies with outcome (live birth or stillbirth) for two calendar years (Bangla 1409 and 1410) were selected for study. These years (falling within 2001–2003 on the Christian calendar) were the most recent to have been checked for accuracy and completeness. The data available were for nearly 600 villages grouped geographically into 16 centres. Average arsenic concentrations for these centres were obtained from the published statistics of the National Hydrochemical Survey.3 The averages used were those for the 13 upazillas in which the centres were located; three centres were in the same upazilla and two in another. Each average was based on seven to 14 wells tested, with values ranging from < 1 µg/l to 81 µg/l. Nine centres were in upazillas with mean arsenic concentration < 10 µg/l, five in upazillas 10 µg/l to < 50 µg/l and two in upazillas estimated to have arsenic concentration of > 50 µg/l. All the information about the family, pregnancy, delivery and outcome was taken from the records routinely collected about each pregnancy and already coded by GK.

Paramedics attached to the villages recorded the information. The nature of the data reflects obstetric practice by GK in rural Bangladesh and relies on informed judgement by the GK-trained paramedics. Low birth weight, for example, does not reflect an objective measure, because neonates were not weighed at birth, but rather it reflects the paramedic's opinion as to whether the weight was low or very low relative to other births in the area; similarly the presence of anaemia was assessed by clinical rather than laboratory indicators. Other possible differences from practice in Europe and North America include the measurement of the length of gestation and recording of neonates observed to breathe but failing to establish viable respiration as stillbirths. In multiple births, the stillbirth of one fetus was treated as a pregnancy ending in stillbirth and the presence of any male among multiple births was treated as a male outcome of the pregnancy.

Role of the funding source

The funding source had no role in study design, collection, analysis or interpretation, in the writing of the report or in the decision to submit.

Ethics

The project was considered and approved by the University of Alberta Health Research Ethics Board.

Statistical procedures

After cross-tabulation of each factor by outcome (live or stillbirth), a reference category was chosen for each, consistent with both prior knowledge of risk of stillbirth and the data specific to this study. For example, old and young mothers are at high risk of stillbirth; in these data, women younger than 21 years and age 30 years or older had higher rates and the reference category was chosen as age 21–30 years. As pregnancies clustered within the 16 centres, a logistic model was fitted (using gllamm within Stata 9) with stillbirth as the outcome and centre-specific random intercepts. First, each socioeconomic, health and exposure factor was entered individually as a fixed effect in this two-level model. A multivariate model was then fitted including all factors other than arsenic, with centre again as a random effect. The final model without arsenic included only factors significantly associated with stillbirth at P < 0.05. Arsenic exposure, as dummy variables contrasting 10 µg/l to < 50 µg/l, and > 50 µg/l with < 10 µg/l, was then added to this best multilevel model to estimate any additional risk associated with concentrations at these two higher levels, having adjusted for potential confounders.

 

Findings

Information was available on outcome for 30 984 deliveries of which 1056 (3.4%) ended in stillbirth. Rates varied with estimated arsenic concentration in the drinking water: 2.96% (499/16 860) at < 10 µg/l, 3.79% (404/10 669) at 10 µg/l to < 50 µg/l and 4.43% (153/3455) in the centres with > 50 µg/l. When each of 26 socioeconomic and health factors were examined individually, six (paternal smoking, malnutrition, treatment for pre-eclampsia or eclampsia, absence of antenatal care and payment of the GK insurance premium) were not related to risk of stillbirth and were not considered further. Three factors (food shortage in the home, anaemia and albumin present in urine), were related to stillbirth in univariate analysis but not after adjustment for other factors in a multivariate model. Maternal death, which occurred in less than 1% of deliveries, was highly related to stillbirth, but only after allowance for other factors: it is included, together with the remaining 16 factors in Table 1, showing the distribution of each of the factors contributing to the multivariate model, together with their univariate odds ratios. Higher rates of stillbirth were associated with a male fetus, multiple birth, mother's age less than 21 years or more than 30 years, no previous pregnancy or three or more pregnancies, one or more previous stillbirths, lower socioeconomic status (as assessed by GK for purposes of payment), no schooling or schooling beyond four years in either the father or the mother, maternal high blood pressure, oedema, gestation above or below the mode of 37–38 weeks, low or very low birth weight, prolonged labour and excess bleeding during labour. Home delivery and maternal smoking were both associated with a lower risk of stillbirth.

 

 

In a multivariate analysis, including the 30 486 pregnancies (971 stillbirths) with no missing data, largely the same factors were found, but pregnancies in young women, multiple previous pregnancies, no schooling for mothers and extended schooling for fathers, were no longer significant (Table 2). Having allowed for all other factors, maternal death seemed to be protective for the fetus, and maternal smoking and home delivery remained negatively associated with risk, the latter reflecting hospital delivery of high-risk cases. In the final analysis (Table 2), the effect of arsenic was estimated having allowed for all factors significantly related to stillbirth: the dose response between arsenic concentration and stillbirth was not diminished. The adjusted odds ratios (with < 10 µg/l as the reference) were 1.23 (95% confidence interval, CI: 0.87–1.74) at 10 µg/l to < 50 µg/l, and 1.80 (95% CI: 1.14–2.86) at > 50 µg/l.

 

 

Discussion

These analyses were made possible by the existence of data by geographical subdistricts for the incidence of stillbirth, average arsenic concentration in tubewells and extensive socioeconomic and health information on all pregnancies in the study. It is remarkable that the GK network of nearly 600 villages together with the recent National Hydrochemical Survey could provide these data in analysable form. However, certain limitations exist. First, the criteria for stillbirth used by the paramedics might have not excluded a few very early neonatal deaths, especially where the delivery was unattended. Second, the socioeconomic information recorded, though collected in accord with training and instructions, was not standardized. Third, the average exposures are based on only 7–14 wells per upazilla and, as there is great local variation within and between villages, these may poorly reflect the arsenic ingestion of pregnant woman individually. A possibility of systematic error occurs in recording information about birth weight and other events at the time of delivery by a paramedic aware that a stillbirth had occurred. None of these limitations, however, is likely to bias upward any estimate of arsenic-related risk.

We believe therefore that the general epidemiological pattern of stillbirth in GK villages is probably reliable and a useful indication of the situation in rural Bangladesh more generally. We believe too that the observed gradient in arsenic-related risk of stillbirth, having taken account of socioeconomic and health factors, is valid and may, if anything, provide an underestimate. This would occur if arsenic in drinking water is associated with other health effects in the mother or fetus (such as short gestation or low birth weight) treated as confounders in this analysis. The high rate of misclassification of individual exposure is also likely to result in an underestimate of the dose–response gradient. We know that about one in four of wells in upazillas classified as 10 µg/l to < 50 µg/l had concentrations of > 50 µg/l and conversely that some 30% of wells in upazillas classified at the higher level had concentrations < 50 µg/l.19 Thus, while ecological exposure estimates may be appropriate for characterizing high risk area – and so focusing public-health intervention – they are more limited in estimating the underlying risk for individuals.

As such, the approach adopted here is an imperfect substitute for a more detailed – and costly – prospective cohort investigation based on a large sample of pregnancies with individual assessment of exposure. Such a study, which is now being planned within GK, will entail the routine identification by paramedics of all pregnancies in some 25 villages over a two-year period, with follow-up to determine outcome. Arsenic exposure will be estimated individually by analysis of well water in current use and, where possible, urine routinely collected in early pregnancy, for cases of stillbirth and congenital abnormality, together with a sample of non-cases. The findings may also help to elucidate some of the more puzzling aspects of the present study, for example the effects of maternal smoking and the influence of education continued beyond four years.

In the meantime, this study and previous reports show that arsenic in drinking water is an important hazard in pregnancy, and every effort is needed to protect women at high risk.

 

Acknowledgements

We are indebted to all the paramedics and other staff of GK who provided the data for this analysis and to Dr Nazmul Huda for help with several aspects of this study.

Competing interests: None declared.

 

References

1. Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol 2005;193:1923-35. PMID:16325593 doi:10.1016/j.ajog.2005.03.074        

2. McClure EM, Nalubamba-Phiri M, Goldenberg RL. Stillbirth in developing countries. Int J Gynaecol Obstet 2006;94:82-90. PMID:16730726 doi:10.1016/j.ijgo.2006.03.023        

3. Arsenic contamination of groundwater in Bangladesh. In: Kinniburgh DG, Smedley PL, eds. BGS Technical Report WC/00/19. Keyworth: British Geological Survey; 2001.        

4. Smith AH, Lingas EO, Rahman M. Contamination of drinking water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 2000;78:1093-103. PMID:11019458        

5. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 1998;27:871-7. PMID:9839746 doi:10.1093/ije/27.5.871        

6. Tondel M, Rahman M, Magnuson A, Chowdhury IA, Faruquee MH, Ahmad SA. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect 1999;107:727-9. PMID:10464073 doi:10.2307/3434658        

7. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, Basu GC, et al. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 2000;108:393-7. PMID:10811564 doi:10.2307/3454378        

8. Rahman M, Vahter M, Wahed MA, Sohel N, Yunus M, Streatfield PK, et al. Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab, Bangladesh. J Epidemiol Community Health 2006;60:242-8. PMID:16476755 doi:10.1136/jech.2005.040212        

9. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, et al. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 2003;14:174-82. PMID:12606883 doi:10.1097/00001648-200303000-00011        

10. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol 2006;163:1138-48. PMID:16624965 doi:10.1093/aje/kwj154        

11. Some drinking water disinfectants and contaminants, including arsenic. Monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC Monographs 84; 2004.        

12. Golub MS, Macintosh MS, Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev 1998;1:199-241. PMID:9644328        

13. Vahter ME, Li L, Nermell B, Rahman A, El Arifeen S, Rahman M, et al. Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. J Health Popul Nutr 2006;24:236-45. PMID:17195565        

14. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, Jalil A, et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 2001;109:629-31. PMID:11445518 doi:10.2307/3455038        

15. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, Dear K, et al. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005;16:82-6. PMID:15613949 doi:10.1097/01.ede.0000147105.94041.e6        

16. von Ehrenstein OS, Guha Mazumder DN, Hira-Smith M, Ghosh N, Yuan Y, Windham G, et al. Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol 2006;163:662-9. PMID:16524957 doi:10.1093/aje/kwj089        

17. Kwok RK, Kaufmann RB, Jakariya M. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. J Health Popul Nutr 2006;24:190-205. PMID:17195560        

18. McDonald C, Hoque R, Huda N, Cherry N. Prevalence of arsenic-related skin lesions in 53 widely scattered villages of Bangladesh: an ecological survey. J Health Popul Nutr 2006;24:228-35. PMID:17195564        

19. McDonald C, Hoque R, Huda N, Cherry N. Risk of arsenic-related skin lesions in Bangladeshi villages at relatively low exposure: a report from Gonoshasthaya Kendra. Bull World Health Organ 2007;85:668-74. PMID:18026622 doi:10.2471/BLT.06.036764        

 

 

(Submitted: 19 April 2007 – Final revised version received: 9 July 2007 – Accepted: 16 July 2008 – Published online: 25 January 2008)

 

 

1 Correspondence to Nicola Cherry (e-mail: nicola.cherry@ualberta.ca).
doi:10.2471/BLT.07.043083

World Health Organization Genebra - Genebra - Switzerland
E-mail: bulletin@who.int